STC2 and breast cancer: Studies have showed that the expression of STC2 is broadly increased in human tumors including renal cell carcinoma, breast cancer, and colorectal cancer (Esseghir et al., 2007; Meyer et al., 2009; Miyazaki et al., 2014).